Ocean Breeze Healthcare exclusively specializes in the full spectrum of FDA-approved growth hormone therapies for children and adults, providing expert clinical support, injection training, and nationwide delivery alongside every prescription.
Growth hormone disorders are conditions that prevent children from developing normal height and physical maturity, or cause adults to experience growth hormone deficiency (GHD), leading to reduced muscle mass, increased body fat, fatigue, and reduced quality of life.
As a pharmacy exclusively focused on growth hormone disorder therapies, Ocean Breeze Healthcare carries the most comprehensive selection of FDA-approved growth hormone medications available, from traditional daily injections to the newest once-weekly formulations, ensuring patients and providers across the USA have access to the full range of treatment options.
Our pharmacists are specialists in growth disorder therapies and are available to counsel patients, caregivers, and providers on optimal use of each medication.
Full Medication Portfolio
Daily & once-weekly options
for patients
Click on any medication below for full prescribing information, patient guides, and downloadable resources.
The first and only FDA-approved once-weekly growth hormone for pediatric patients with growth hormone deficiency. TransCon technology delivers steady, predictable hormone release.
A leuprolide acetate injection that inhibits gonadotropin-releasing hormone action, used for the treatment of central precocious puberty in children.
A pre-filled, multi-dose growth hormone pen indicated for multiple conditions including GHD, Turner syndrome, Noonan syndrome, and chronic renal insufficiency.
A biosimilar somatropin growth hormone replacement available in both vial and pen formulations, providing flexible treatment options for patients.
A histrelin acetate subcutaneous implant providing continuous LHRH agonist therapy for the treatment of central precocious puberty (CPP) in children.
A somatropin growth hormone indicated for treatment of growth failure in pediatric patients due to growth hormone deficiency, Turner syndrome, and other conditions.
A somatropin growth hormone available in multiple delivery devices, including GoQuick Pen, Pen 5, Pen 12, Mixer, and MiniQuick, for patient and caregiver convenience.
A once-weekly somapacitan growth hormone injection that provides 313 more injection-free days per year compared to daily therapy, for patients.
A once-weekly somatrogon growth hormone injection approved for treatment of growth hormone deficiency in pediatric patients aged 3 years and older.
Our clinical pharmacists are specialists in growth hormone therapy and are ready to assist patients, caregivers, and providers.